Chuck Royce's COLL Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 251,153 shares of Collegium Pharmaceutical, Inc. (COLL) worth $11.63 M, representing 0.12% of the portfolio. First purchased in 2017-Q4, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in COLL, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2021, adding 175,509 shares. Largest reduction occurred in Q3 2022, reducing 431,923 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Collegium Pharmaceutical (COLL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Collegium Pharmaceutical (COLL) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -54,987 | Reduce 17.96% | 251,153 | $46.30 |
| Q3 2025 | +328 | Add 0.11% | 306,140 | $34.99 |
| Q2 2025 | +3,210 | Add 1.06% | 305,812 | $29.57 |
| Q1 2025 | -36,927 | Reduce 10.88% | 302,602 | $29.85 |
| Q4 2024 | +33,674 | Add 11.01% | 339,529 | $28.65 |
| Q3 2024 | +4,966 | Add 1.65% | 305,855 | $38.64 |
| Q2 2024 | +12,180 | Add 4.22% | 300,889 | $32.20 |
| Q1 2024 | +145,626 | Add 101.78% | 288,709 | $38.82 |
| Q4 2023 | +121,853 | Add 573.97% | 143,083 | $30.78 |
| Q3 2023 | +21,230 | New Buy | 21,230 | $22.35 |
| Q1 2023 | -14,477 | Sold Out | 0 | $0.00 |
| Q4 2022 | -13,843 | Reduce 48.88% | 14,477 | $23.20 |
| Q3 2022 | -431,923 | Reduce 93.85% | 28,320 | $16.03 |
| Q2 2022 | +168,989 | Add 58.02% | 460,243 | $17.72 |
| Q1 2022 | -32,632 | Reduce 10.08% | 291,254 | $20.36 |
| Q4 2021 | +148,377 | Add 84.54% | 323,886 | $18.68 |
| Q3 2021 | +175,509 | New Buy | 175,509 | $19.74 |
| Q1 2020 | -1,421 | Sold Out | 0 | $0.00 |
| Q4 2019 | -1,060 | Reduce 42.72% | 1,421 | $20.41 |
| Q3 2019 | +1,013 | Add 69.01% | 2,481 | $11.29 |
| Q2 2019 | +373 | Add 34.06% | 1,468 | $12.94 |
| Q1 2019 | +1,095 | New Buy | 1,095 | $15.53 |
| Q3 2018 | -138,000 | Sold Out | 0 | $0.00 |
| Q2 2018 | -32,000 | Reduce 18.82% | 138,000 | $23.85 |
| Q1 2018 | +33,000 | Add 24.09% | 170,000 | $25.55 |
| Q4 2017 | +137,000 | New Buy | 137,000 | $18.46 |
Chuck Royce's Collegium Pharmaceutical Investment FAQs
Chuck Royce first purchased Collegium Pharmaceutical, Inc. (COLL) in Q4 2017, acquiring 137,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Collegium Pharmaceutical, Inc. (COLL) for 26 quarters since Q4 2017.
Chuck Royce's largest addition to Collegium Pharmaceutical, Inc. (COLL) was in Q3 2021, adding 175,509 shares worth $3.46 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 251,153 shares of Collegium Pharmaceutical, Inc. (COLL), valued at approximately $11.63 M.
As of the Q4 2025 filing, Collegium Pharmaceutical, Inc. (COLL) represents approximately 0.12% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Collegium Pharmaceutical, Inc. (COLL) was 460,243 shares, as reported at the end of Q2 2022.